{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:48:40Z","timestamp":1778507320449,"version":"3.51.4"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0024204","type":"journal-article","created":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T21:47:47Z","timestamp":1314913667000},"page":"e24204","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["Adult Patients with Congenital Adrenal Hyperplasia Have Elevated Blood Pressure but Otherwise a Normal Cardiovascular Risk Profile"],"prefix":"10.1371","volume":"6","author":[{"given":"Christiaan F.","family":"Mooij","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne Margot","family":"Kroese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred C. G. J.","family":"Sweep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ad R. M. M.","family":"Hermus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cees J.","family":"Tack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,9,1]]},"reference":[{"key":"ref1","first-page":"245","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.","volume":"21","author":"PC White","year":"2000","journal-title":"Endocr Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.7326\/0003-4819-136-4-200202190-00012","article-title":"NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.","volume":"136","author":"DP Merke","year":"2002","journal-title":"Ann Intern Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and mortality in Cushing&apos;s disease: an epidemiological approach.","volume":"40","author":"J Etxabe","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1210\/jc.2006-0076","article-title":"Premature mortality in patients with Addison&apos;s disease: a population-based study.","volume":"91","author":"R Bergthorsdottir","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2265.2009.03690.x","article-title":"Unfavourable trends in cardiovascular and metabolic risk in paediatric and adult patients with congenital adrenal hyperplasia?","volume":"73","author":"CF Mooij","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/172460089701200102","article-title":"A sensitive and robust assay for urokinase and tissue-type plasminogen activators (uPA and tPA) and their inhibitor type I (PAI-1) in breast tumor cytosols.","volume":"12","author":"N Grebenschikov","year":"1997","journal-title":"Int J Biol Markers"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/(SICI)1097-0215(19990517)81:4<598::AID-IJC16>3.0.CO;2-9","article-title":"ELISA for complexes of urokinase-type and tissue-type plasminogen activators with their type-1 inhibitor (uPA-PAI-1 and tPA-PAI-1).","volume":"81","author":"N Grebenschikov","year":"1999","journal-title":"Int J Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.","volume":"28","author":"DR Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1210\/jc.2006-1350","article-title":"Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.","volume":"92","author":"H Falhammar","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1210\/jc.2006-1711","article-title":"Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs, and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.","volume":"92","author":"P Sartorato","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.beem.2006.07.001","article-title":"Cortisol metabolism in hypertension.","volume":"20","author":"F Hammer","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.HYP.0000193502.77417.17","article-title":"Mechanisms of mineralocorticoid action.","volume":"46","author":"PJ Fuller","year":"2005","journal-title":"Hypertension"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1651-2227.2009.01231.x","article-title":"Adiponectin levels are high in children with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.","volume":"98","author":"TM Volkl","year":"2009","journal-title":"Acta Paediatr"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1001\/jama.291.14.1730","article-title":"Plasma adiponectin levels and risk of myocardial infarction in men.","volume":"291","author":"T Pischon","year":"2004","journal-title":"Jama"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0140-6736(03)12255-6","article-title":"Adiponectin and protection against type 2 diabetes mellitus.","volume":"361","author":"J Spranger","year":"2003","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.","volume":"86","author":"C Weyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/oby.2005.74","article-title":"Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha.","volume":"13","author":"M Degawa-Yamauchi","year":"2005","journal-title":"Obes Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1210\/jc.2004-0303","article-title":"Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels.","volume":"89","author":"A Bottner","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1530\/EJE-09-0523","article-title":"Pioglitazone improves insulin resistance and decreases blood pressure in adult patients with congenital adrenal hyperplasia.","volume":"161","author":"JM Kroese","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1210\/me.2008-0283","article-title":"Minireview: latest perspectives on antiinflammatory actions of glucocorticoids.","volume":"23","author":"K De Bosscher","year":"2009","journal-title":"Mol Endocrinol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1210\/jc.2010-0917","article-title":"Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients.","volume":"95","author":"W Arlt","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1530\/EJE-10-0877","article-title":"Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.","volume":"164","author":"H Falhammar","year":"2011","journal-title":"Eur J Endocrinol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0024204","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T22:01:56Z","timestamp":1712786516000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0024204"}},"subtitle":[],"editor":[{"given":"German","family":"Malaga","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,9,1]]},"references-count":22,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2011,9,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0024204","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,1]]}}}